speb/financial-data huggingface dataset:
Financial ratios for BYD.TO — quarterly report dated 2025-12-31
Total revenue: 579455474.4525547
Gross profit: 268550364.9635036
Operating income: 29464233.576642334
Net income: 3496350.3649635036
Capital expenditures: 4833576.642335766
Operating cash flow: 58308759.12408759
Depreciation & amortization: 46162773.72262774
Net tangible assets: 482302189.78102183
Owner earnings: 44825547.44525547
Return on net tangible assets (%): 9.294079188321222
Capex to operating income (%): 16.404895208839122
Buffett classification: The Great
Stock price: 159.25547445255475
P/E ratio: 330.4541758920021
Shares outstanding: 27830064
Book value: 1255154014.5985398
P/B ratio: 3.531112512740171
Market cap (USD): 4432090046.364964
Debt to equity: 0.9983553941965423
Current ratio: 3.1433249629205404
Quick ratio: 3.000075522521446
Effective tax rate (%): 43.48749410099103
Interest coverage ratio: 2.679100019911064
COGS to revenue (%): 53.65470225003589
Free cash flow (dilution-adjusted): 46517518.248175174
Buyback yield (%): 0
Retained earnings: 137795620.43795618
Inventory turnover: 6.23777165953957
Receivables turnover: 5.375865104625178
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1931053725505962
FCF margin (%): 8.027798562456068
Revenue growth (%): 1.9277292731110796
Rule of 40 score: 9.955527835567148
Financial ratios for BYD.TO — annual report dated 2025-12-31
Total revenue: 2294010218.978102
Gross profit: 1064667153.2846714
Operating income: 96594160.5839416
Net income: 13445255.474452553
Capital expenditures: 181751.82481751824
Operating cash flow: 257656204.37956202
Depreciation & amortization: 178081751.8248175
Net tangible assets: 482302189.78102183
Owner earnings: 191345255.47445256
Return on net tangible assets (%): 39.67331260953396
Capex to operating income (%): 0.18816026115737455
Buffett classification: The Great
Stock price: 159.25547445255475
P/E ratio: 329.6397048599349
Shares outstanding: 27830064
Book value: 1255154014.5985398
P/B ratio: 3.531112512740171
Market cap (USD): 4432090046.364964
Debt to equity: 0.9983553941965423
Current ratio: 3.1433249629205404
Quick ratio: 3.000075522521446
Effective tax rate (%): 35.87244116418326
Interest coverage ratio: 1.8993584315301477
COGS to revenue (%): 53.589258475102085
Free cash flow (dilution-adjusted): 208956204.37956202
Buyback yield (%): 0
Retained earnings: 137795620.43795618
Inventory turnover: 24.66463593228282
Receivables turnover: 21.282548926660798
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9114206602365997
FCF margin (%): 9.108773912639515
Revenue growth (%): 6.8426453189477305
Rule of 40 score: 15.951419231587245
Financial ratios for CCCC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1492000
Buffett classification: The Gruesome
Stock price: 32.2
Shares outstanding: 110567222
Market cap (USD): 3560264548.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCCC — annual report dated 2022-12-31
Total revenue: 31096000
Operating income: -129534000
Net income: -128175000
Capital expenditures: 5496000
Operating cash flow: -105939000
Depreciation & amortization: 1676000
Net tangible assets: 289234000
Owner earnings: -131995000
Return on net tangible assets (%): -45.636059384443044
Buffett classification: The Gruesome
Stock price: 5.9
Shares outstanding: 110567222
Book value: 289234000
P/B ratio: 2.2554285104794043
Market cap (USD): 652346609.8000001
Debt to equity: 0.30132003844637906
Current ratio: 6.455282180218202
Quick ratio: 6.455282180218202
Interest coverage ratio: -58.45397111913358
COGS to revenue (%): 0
R&D to revenue (%): 378.9587085155647
SG&A to revenue (%): 137.6029071263185
Free cash flow (dilution-adjusted): -141451000
Buyback yield (%): 0
Retained earnings: -395890000
Receivables turnover: 21.110658520027155
Capitalized R&D asset: 117841000
ROCI (R&D-adjusted, %): -10.111048297248423
FCF margin (%): -454.8848726524311
Rule of 40 score: -454.8848726524311
Financial ratios for CCCC — annual report dated 2023-12-31
Total revenue: 20756000
Operating income: -139031000
Net income: -132493000
Capital expenditures: 1708000
Operating cash flow: -106838000
Depreciation & amortization: 1880000
Net tangible assets: 246114000
Owner earnings: -132321000
Return on net tangible assets (%): -53.7641093151954
Buffett classification: The Gruesome
Stock price: 5.65
Shares outstanding: 110567222
Book value: 246114000
P/B ratio: 2.538274150596878
Market cap (USD): 624704804.3000001
Debt to equity: 0.28838668259424494
Current ratio: 6.341229013702474
Quick ratio: 6.341229013702474
Interest coverage ratio: -101.26074289876183
COGS to revenue (%): 0
R&D to revenue (%): 567.0938523800347
SG&A to revenue (%): 202.74137598766623
Free cash flow (dilution-adjusted): -135781000
Buyback yield (%): 0.017608316638969695
Retained earnings: -528383000
Receivables turnover: 1.759132129841512
Capitalized R&D asset: 196659470
ROCI (R&D-adjusted, %): -18.82562604389307
FCF margin (%): -654.1771054153016
Revenue growth (%): -33.25186519166452
Rule of 40 score: -687.4289706069661
Financial ratios for CCCC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.7
Shares outstanding: 110567222
Market cap (USD): 630233165.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCCC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 110567222
Market cap (USD): 398041999.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCCC — annual report dated 2024-12-31
Total revenue: 35584000
Operating income: -117177000
Net income: -105316000
Capital expenditures: 180000
Operating cash flow: -65157000
Depreciation & amortization: 1818000
Net tangible assets: 215986000
Owner earnings: -103678000
Return on net tangible assets (%): -48.00218532682674
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 110567222
Book value: 215986000
P/B ratio: 1.8429064809756188
Market cap (USD): 398041999.2
Debt to equity: 0.30444565851490374
Current ratio: 5.705713084091462
Quick ratio: 5.705713084091462
COGS to revenue (%): 0
R&D to revenue (%): 310.91782823741005
SG&A to revenue (%): 118.37904676258992
Free cash flow (dilution-adjusted): -94999000
Buyback yield (%): 0.04873857542417851
Retained earnings: -633699000
Receivables turnover: 11.47130883301096
Capitalized R&D asset: 228387550
ROCI (R&D-adjusted, %): -22.885096581652718
FCF margin (%): -266.97111061151077
Revenue growth (%): 71.43958373482366
Rule of 40 score: -195.5315268766871
Financial ratios for CCCC — quarterly report dated 2025-03-31
Total revenue: 7238000
Operating income: -29164000
Net income: -26322000
Capital expenditures: 0
Operating cash flow: -33285000
Depreciation & amortization: 456000
Net tangible assets: 195140000
Owner earnings: -25866000
Return on net tangible assets (%): -13.25509890335144
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 110567222
Book value: 195140000
P/B ratio: 0.90656736291893
Market cap (USD): 176907555.20000002
Debt to equity: 0.3298452393153633
Current ratio: 5.696594806467418
Quick ratio: 5.696594806467418
COGS to revenue (%): 0
R&D to revenue (%): 374.025974025974
SG&A to revenue (%): 128.9030118817353
Free cash flow (dilution-adjusted): -38792000
Buyback yield (%): 0.08761638236691882
Retained earnings: -660021000
Receivables turnover: 0.9015944195316392
Capitalized R&D asset: 27072000
ROCI (R&D-adjusted, %): -3.6353409031447854
FCF margin (%): -535.949157225753
Rule of 40 score: -535.949157225753
Financial ratios for CCCC — quarterly report dated 2025-06-30
Total revenue: 6463000
Operating income: -28501000
Net income: -26020000
Capital expenditures: 185000
Operating cash flow: -12057000
Depreciation & amortization: 615000
Net tangible assets: 174064000
Owner earnings: -25590000
Return on net tangible assets (%): -14.70148910745473
Buffett classification: The Gruesome
Stock price: 1.43
Shares outstanding: 110567222
Book value: 174064000
P/B ratio: 0.9083505346309404
Market cap (USD): 158111127.45999998
Debt to equity: 0.3614934736648589
Current ratio: 5.05508817707396
Quick ratio: 5.05508817707396
COGS to revenue (%): 0
R&D to revenue (%): 405.33807829181495
SG&A to revenue (%): 135.6490793749033
Free cash flow (dilution-adjusted): -17234000
Buyback yield (%): 0
Retained earnings: -686041000
Receivables turnover: 2.994902687673772
Capitalized R&D asset: 44335240
ROCI (R&D-adjusted, %): -6.7678512211258886
FCF margin (%): -266.65635153953275
Revenue growth (%): -10.707377728654324
Rule of 40 score: -277.36372926818706
Financial ratios for CCCC — quarterly report dated 2025-09-30
Total revenue: 11230000
Operating income: -23679000
Net income: -32166000
Capital expenditures: 411000
Operating cash flow: -31207000
Depreciation & amortization: 460000
Net tangible assets: 154408000
Owner earnings: -32117000
Return on net tangible assets (%): -20.80008807833791
Buffett classification: The Gruesome
Stock price: 2.22
Shares outstanding: 110567222
Book value: 154408000
P/B ratio: 1.5896795039117146
Market cap (USD): 245459232.84000003
Debt to equity: 0.3980558002176053
Current ratio: 5.755014605647517
Quick ratio: 5.755014605647517
COGS to revenue (%): 0
R&D to revenue (%): 231.42475512021372
SG&A to revenue (%): 79.43009795191452
Free cash flow (dilution-adjusted): -36211000
Buyback yield (%): 0.009777591057511428
Retained earnings: -718207000
Receivables turnover: 1.7166004280036686
Capitalized R&D asset: 52474750
ROCI (R&D-adjusted, %): -8.548870889627809
FCF margin (%): -322.4487978628673
Revenue growth (%): 73.75831657125174
Rule of 40 score: -248.69048129161558
Financial ratios for CCCC — annual report dated 2025-12-31
Total revenue: 35947000
Operating income: -104489000
Net income: -104994000
Capital expenditures: 607000
Operating cash flow: -98694000
Depreciation & amortization: 1959000
Net tangible assets: 256587000
Owner earnings: -103642000
Return on net tangible assets (%): -40.39253742395367
Buffett classification: The Gruesome
Stock price: 1.91
Shares outstanding: 110567222
Book value: 256587000
P/B ratio: 0.8230479097538067
Market cap (USD): 211183394.01999998
Debt to equity: 0.2337686632604146
Current ratio: 7.8139379995156215
Quick ratio: 7.8139379995156215
COGS to revenue (%): 0
R&D to revenue (%): 289.982474198125
SG&A to revenue (%): 100.69268645505885
Free cash flow (dilution-adjusted): -118400000
Buyback yield (%): 0.09138976144200148
Retained earnings: -738693000
Receivables turnover: 14.97167846730529
Capitalized R&D asset: 217209770
ROCI (R&D-adjusted, %): -20.452725901425225
FCF margin (%): -329.37380031713354
Revenue growth (%): 1.020121402877698
Rule of 40 score: -328.35367891425585
Financial ratios for CCCC — quarterly report dated 2025-12-31
Total revenue: 11016000
Operating income: -23145000
Net income: -20486000
Capital expenditures: 11000
Operating cash flow: -22145000
Depreciation & amortization: 428000
Net tangible assets: 256587000
Owner earnings: -20069000
Return on net tangible assets (%): -7.8215186272102635
Buffett classification: The Gruesome
Stock price: 1.91
Shares outstanding: 110567222
Book value: 256587000
P/B ratio: 0.8230479097538067
Market cap (USD): 211183394.01999998
Debt to equity: 0.2337686632604146
Current ratio: 7.8139379995156215
Quick ratio: 7.8139379995156215
COGS to revenue (%): 0
R&D to revenue (%): 226.77923021060278
SG&A to revenue (%): 83.3242556281772
Free cash flow (dilution-adjusted): -26163000
Buyback yield (%): 0.006629309120145185
Retained earnings: -738693000
Receivables turnover: 4.588088296543107
Capitalized R&D asset: 51039640
ROCI (R&D-adjusted, %): -6.33433208876088
FCF margin (%): -237.5
Revenue growth (%): -1.9056099732858416
Rule of 40 score: -239.40560997328583
Financial ratios for CVCG.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.01
Shares outstanding: 196305993
Market cap (USD): 1963059.93
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVCG.L — annual report dated 2022-12-31
Total revenue: -22174943.373493977
Net income: -40689656.62650602
Capital expenditures: 0
Operating cash flow: 16376521.686746988
Net tangible assets: 285348277.1084337
Owner earnings: -40689656.62650602
Return on net tangible assets (%): -14.2596468564076
Buffett classification: The Gruesome
Stock price: 0.008192771084337351
Shares outstanding: 196305993
Book value: 285348277.1084337
P/B ratio: 0.0056362354082880005
Market cap (USD): 1608290.0631325305
Debt to equity: 0
Free cash flow (dilution-adjusted): 16376521.686746988
Buyback yield (%): 2486.974805825359
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVCG.L — annual report dated 2023-12-31
Total revenue: 65814769.62025316
Net income: 40179281.01265822
Capital expenditures: 0
Operating cash flow: 23495264.556962024
Net tangible assets: 316391554.43037975
Owner earnings: 40179281.01265822
Return on net tangible assets (%): 12.699226780877762
Buffett classification: The Gruesome
Stock price: 0.010126582278481013
P/E ratio: 0.04947596720924747
Shares outstanding: 196305993
Book value: 316391554.43037975
P/B ratio: 0.006283065277935054
Market cap (USD): 1987908.7898734177
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 2.506430206078171
Free cash flow (dilution-adjusted): 23495264.556962024
Buyback yield (%): 1375.0155223228462
Capitalized R&D asset: 0
FCF margin (%): 35.699075895164775
Rule of 40 score: 35.699075895164775
Financial ratios for CVCG.L — annual report dated 2024-12-31
Total revenue: 54646250
Net income: 25685000
Capital expenditures: 0
Operating cash flow: 27518750
Net tangible assets: 335297500
Owner earnings: 25685000
Return on net tangible assets (%): 7.6603613209165
Buffett classification: The Gruesome
Stock price: 0.01325
P/E ratio: 0.10126744820907144
Shares outstanding: 196305993
Book value: 335297500
P/B ratio: 0.007757452433286857
Market cap (USD): 2601054.4072499997
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 3.4906329345563507
Free cash flow (dilution-adjusted): 27518750
Buyback yield (%): 665.0187689956097
Capitalized R&D asset: 0
FCF margin (%): 50.35798430816387
Revenue growth (%): -16.96962503203274
Rule of 40 score: 33.388359276131126
Financial ratios for CVCG.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 335297500
Buffett classification: The Gruesome
Stock price: 0.01325
Shares outstanding: 196305993
Book value: 335297500
P/B ratio: 0.007757452433286857
Market cap (USD): 2601054.4072499997
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVCG.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 397327397.260274
Buffett classification: The Gruesome
Stock price: 0.015068493150684934
Shares outstanding: 196305993
Book value: 397327397.26027393
P/B ratio: 0.007444831469855096
Market cap (USD): 2958035.5109589044
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYTO.V — quarterly report dated 2024-09-30
Capital expenditures: 269369.6296296296
Buffett classification: The Gruesome
Stock price: 0.18518518518518517
Shares outstanding: 67685221
Market cap (USD): 12534300.185185185
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYTO.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -3604329.3706293707
Net income: -5498390.909090909
Capital expenditures: 912433.5664335665
Operating cash flow: -3335469.9300699304
Depreciation & amortization: 494584.61538461543
Net tangible assets: 2049800.6993006994
Owner earnings: -5916239.860139861
Return on net tangible assets (%): -288.6251264407422
Buffett classification: The Gruesome
Stock price: 0.20279720279720279
Shares outstanding: 67685221
Book value: 2049800.6993006992
P/B ratio: 6.696442973306292
Market cap (USD): 13726373.48951049
Debt to equity: 0.5247479287599169
Current ratio: 2.6689135223851777
Quick ratio: 2.6689135223851777
Interest coverage ratio: -50.428449827802126
Free cash flow (dilution-adjusted): -4247903.496503497
Buyback yield (%): 0
Retained earnings: -18575169.230769232
Receivables turnover: 0
Capitalized R&D asset: 347664.97247360484
ROCI (R&D-adjusted, %): -114.77716875812544
Rule of 40 score: 0
Financial ratios for CYTO.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -822516.0839160839
Net income: -868911.8881118882
Capital expenditures: 69947.55244755244
Operating cash flow: -529394.4055944056
Depreciation & amortization: 124720.27972027972
Net tangible assets: 2049800.6993006994
Owner earnings: -814139.1608391609
Return on net tangible assets (%): -39.717966781692915
Buffett classification: The Gruesome
Stock price: 0.20279720279720279
Shares outstanding: 67685221
Book value: 2049800.6993006992
P/B ratio: 6.696442973306292
Market cap (USD): 13726373.48951049
Debt to equity: 0.5247479287599169
Current ratio: 2.6689135223851777
Quick ratio: 2.6689135223851777
Interest coverage ratio: -48.6675769612711
Free cash flow (dilution-adjusted): -599341.958041958
Buyback yield (%): 0
Retained earnings: -18575169.230769232
Receivables turnover: 0
Capitalized R&D asset: 857.3426573426574
ROCI (R&D-adjusted, %): -27.61985642012825
Rule of 40 score: 0
Financial ratios for CYTO.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -797174.1258741259
Net income: -811313.2867132868
Capital expenditures: 2195.104895104895
Operating cash flow: -509100.69930069934
Depreciation & amortization: 178190.9090909091
Net tangible assets: 1238487.4125874126
Owner earnings: -635317.4825174826
Return on net tangible assets (%): -51.297855437238184
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 67685221
Book value: 1238487.4125874126
P/B ratio: 5.350498572305378
Market cap (USD): 6626525.132867134
Debt to equity: 0.8395561470483113
Current ratio: 1.2312465761314337
Quick ratio: 1.2312465761314337
Interest coverage ratio: -46.08315478837368
Free cash flow (dilution-adjusted): -511295.80419580423
Buyback yield (%): 0
Retained earnings: -19386482.51748252
Receivables turnover: 0
Capitalized R&D asset: 17014.979020979023
ROCI (R&D-adjusted, %): -36.76988831991119
Rule of 40 score: 0
Financial ratios for CYTO.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -808678.8321167883
Net income: -824601.4598540146
Capital expenditures: 1.4598540145985401
Operating cash flow: -661656.9343065693
Depreciation & amortization: 131481.02189781022
Net tangible assets: 1556559.1240875912
Owner earnings: -693121.897810219
Return on net tangible assets (%): -44.52910828019504
Buffett classification: The Gruesome
Stock price: 0.12408759124087591
Shares outstanding: 67685221
Book value: 1556559.1240875912
P/B ratio: 5.395809196402697
Market cap (USD): 8398896.03649635
Debt to equity: 0.672843807649851
Current ratio: 1.8505582575129527
Quick ratio: 1.8505582575129527
Interest coverage ratio: -49.01951241095527
Free cash flow (dilution-adjusted): -661658.3941605838
Buyback yield (%): 0
Retained earnings: -21060127.007299267
Receivables turnover: 0
Capitalized R&D asset: 37283.499361951915
ROCI (R&D-adjusted, %): -32.249665629250174
Rule of 40 score: 0
Financial ratios for CYTO.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -728432.3741007195
Net income: -744846.0431654677
Capital expenditures: 6651.079136690648
Operating cash flow: -575680.5755395684
Depreciation & amortization: 62358.27338129497
Net tangible assets: 839407.9136690648
Owner earnings: -689138.8489208634
Return on net tangible assets (%): -82.09820728382546
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 67685221
Book value: 839407.9136690649
P/B ratio: 14.502604396555638
Market cap (USD): 12173600.899280576
Debt to equity: 1.1844345577603945
Current ratio: 0.6606059148448334
Quick ratio: 0.6606059148448334
Interest coverage ratio: -44.379618671926366
Free cash flow (dilution-adjusted): -582331.654676259
Buyback yield (%): 0
Retained earnings: -21501949.64028777
Receivables turnover: 0
Capitalized R&D asset: 76232.72589564508
ROCI (R&D-adjusted, %): -40.711339616363944
Rule of 40 score: 0
Financial ratios for DENORA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.258604773836213
Shares outstanding: 5308634
Market cap (USD): 27916008.09494923
Buyback yield (%): 0
Retained earnings: 8163550.046155876
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DENORA.NS — annual report dated 2023-03-31
Total revenue: 8838684.531059684
Gross profit: 5141559.074299635
Operating income: 3014701.583434836
Net income: 2469671.132764921
Capital expenditures: 445883.0694275274
Operating cash flow: 1738733.252131547
Depreciation & amortization: 166711.32764920828
Net tangible assets: 12369622.411693059
Owner earnings: 2190499.390986602
Return on net tangible assets (%): 17.70870054138365
Capex to operating income (%): 14.790288759509831
Buffett classification: The Great
Stock price: 10.347381242387334
P/E ratio: 22.24201398540146
Shares outstanding: 5308634
Book value: 12384421.437271621
P/B ratio: 4.435448208261332
Market cap (USD): 54930459.87429964
Debt to equity: 0
Current ratio: 7.610935601458079
Quick ratio: 5.502721013292095
Effective tax rate (%): 25.32685154494899
Interest coverage ratio: 1903.9
COGS to revenue (%): 41.82891066841589
SG&A to revenue (%): 6.357833463790005
Free cash flow (dilution-adjusted): 1292850.1827040196
Buyback yield (%): 0
Retained earnings: 9945103.53227771
Inventory turnover: 1.0602511483312085
Receivables turnover: 4.260770003111954
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.246256630796285
FCF margin (%): 14.627178718290759
Rule of 40 score: 14.627178718290759
Financial ratios for DENORA.NS — annual report dated 2024-03-31
Total revenue: 8841239.956829356
Gross profit: 5274481.352680177
Operating income: 2512063.7966182996
Net income: 2279338.050125914
Capital expenditures: 826010.3129871687
Operating cash flow: 1926022.3048327137
Depreciation & amortization: 137402.56625494664
Net tangible assets: 14296198.584962226
Owner earnings: 1590730.3033936922
Return on net tangible assets (%): 11.1269460475104
Capex to operating income (%): 32.88174106482211
Buffett classification: The Good
Stock price: 19.468090211132438
P/E ratio: 45.34165768178866
Shares outstanding: 5308634
Book value: 14352932.00623576
P/B ratio: 7.200547286434853
Market cap (USD): 103348965.60988484
Debt to equity: 0
Current ratio: 14.477699698838377
Quick ratio: 10.524953391653522
Effective tax rate (%): 24.647666771061697
COGS to revenue (%): 40.3422893345866
SG&A to revenue (%): 2.5993155840932305
Free cash flow (dilution-adjusted): 1094735.579805732
Buyback yield (%): 0
Retained earnings: 11943278.570572011
Inventory turnover: 1.079118367346939
Receivables turnover: 7.213860785503219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.500515873446844
FCF margin (%): 12.382149847206794
Revenue growth (%): 0.028911833663616722
Rule of 40 score: 12.41106168087041
Financial ratios for DENORA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 14855984.233158147
Buffett classification: The Gruesome
Stock price: 18.17068800764453
Shares outstanding: 5308634
Book value: 14902054.467271859
P/B ratio: 6.473035806748958
Market cap (USD): 96461532.160774
Debt to equity: 0
Current ratio: 5.80522057940284
Quick ratio: 4.228967008403273
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DENORA.NS — annual report dated 2025-03-31
Total revenue: 8017582.417582417
Gross profit: 4779261.164367547
Operating income: -363420.6219312602
Net income: 197907.41173719897
Capital expenditures: 377858.31190086505
Operating cash flow: 365992.5181201777
Depreciation & amortization: 198866.02758943182
Net tangible assets: 14011012.391863454
Owner earnings: 18915.127425765735
Return on net tangible assets (%): 0.1350018606560524
Buffett classification: The Gruesome
Stock price: 8.010269576379974
P/E ratio: 214.86607827908614
Shares outstanding: 5308634
Book value: 14046072.013093289
P/B ratio: 3.027436380982329
Market cap (USD): 42523589.422336325
Debt to equity: 0
Current ratio: 4.973487865388664
Quick ratio: 3.5395347559803354
Effective tax rate (%): 38.56510378864857
COGS to revenue (%): 40.3902458939903
SG&A to revenue (%): 3.9701147816349383
Free cash flow (dilution-adjusted): -11865.793780687396
Buyback yield (%): 0
Retained earnings: 11716880.991349075
Inventory turnover: 0.8842404315765953
Receivables turnover: 5.111718977095709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.58057500327895
FCF margin (%): -0.14799715378872713
Revenue growth (%): -9.316086242074116
Rule of 40 score: -9.464083395862843
Financial ratios for DENORA.NS — quarterly report dated 2025-03-31
Total revenue: 2353413.6076689265
Gross profit: 1320434.8842646715
Operating income: 395499.1816693944
Net income: 390542.43628711713
Capital expenditures: 0
Depreciation & amortization: 52092.58826280102
Net tangible assets: 14011012.391863454
Owner earnings: 442635.02454991813
Return on net tangible assets (%): 3.1591937268356665
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.010269576379974
P/E ratio: 27.220850713822326
Shares outstanding: 5308634
Book value: 14046072.013093289
P/B ratio: 3.027436380982329
Market cap (USD): 42523589.422336325
Debt to equity: 0
Current ratio: 4.973487865388664
Quick ratio: 3.5395347559803354
Effective tax rate (%): 29.758200168208575
COGS to revenue (%): 43.89278280868905
Buyback yield (%): 0
Retained earnings: 11716880.991349075
Inventory turnover: 0.28206020365818624
Receivables turnover: 1.5004509305566942
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8083582505848153
Rule of 40 score: 0
Financial ratios for DENORA.NS — quarterly report dated 2025-06-30
Total revenue: 4910987.596536391
Gross profit: 2150912.707699509
Operating income: 232284.10952492396
Net income: 380201.26374912245
Capital expenditures: 0
Depreciation & amortization: 54025.27498244793
Owner earnings: 434226.53873157036
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.32295810905687
P/E ratio: 36.03407696356026
Shares outstanding: 5308634
Market cap (USD): 54800806.398315005
Effective tax rate (%): 25.169848690725686
COGS to revenue (%): 56.20203339107396
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 108.67507439122699
Rule of 40 score: 108.67507439122699
Financial ratios for DENORA.NS — quarterly report dated 2025-09-30
Total revenue: 2462694.475760992
Gross profit: 1557271.702367531
Operating income: 395310.03382187145
Net income: 436527.6211950394
Capital expenditures: 0
Depreciation & amortization: 58354.00225479143
Net tangible assets: 14299661.78128523
Owner earnings: 494881.62344983086
Return on net tangible assets (%): 3.4607925069774046
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.343855693348365
P/E ratio: 41.08696127579108
Shares outstanding: 5308634
Book value: 14344306.651634723
P/B ratio: 3.4580346913560844
Market cap (USD): 49603110.02480271
Debt to equity: 0
Current ratio: 2.8856321790647304
Quick ratio: 2.115899495200613
Effective tax rate (%): 25.6114195692686
COGS to revenue (%): 36.76553394280378
Buyback yield (%): 0
Inventory turnover: 0.21981995297646909
Receivables turnover: 1.7733767393528066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7452451061371073
Revenue growth (%): -49.85337618246328
Rule of 40 score: -49.85337618246328
Financial ratios for DENORA.NS — quarterly report dated 2025-12-31
Total revenue: 3992581.0404366716
Gross profit: 1621766.7372173332
Operating income: 217288.62648991868
Net income: 286487.69076528907
Capital expenditures: 0
Depreciation & amortization: 58393.67271917122
Owner earnings: 344881.3634844603
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.642865099699232
P/E ratio: 27.161793301214203
Shares outstanding: 5308634
Market cap (USD): 40573173.52567673
Effective tax rate (%): 23.935997160687354
COGS to revenue (%): 59.380492949494155
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 62.12246706741536
Rule of 40 score: 62.12246706741536
Financial ratios for DKL.L — annual report dated 2021-12-31
Total revenue: 42489772.72727273
Gross profit: 7398863.636363637
Operating income: 3002272.727272727
Net income: 860227.2727272727
Capital expenditures: 5190909.090909091
Operating cash flow: -1479545.4545454546
Depreciation & amortization: 2145454.5454545454
Net tangible assets: 18188636.363636363
Owner earnings: -2185227.2727272725
Return on net tangible assets (%): -12.014244658253153
Capex to operating income (%): 172.8993186979561
Buffett classification: The Gruesome
Stock price: 0.0006756756756756757
P/E ratio: 0.9504873763433184
Shares outstanding: 1210100042
Book value: 18562500
P/B ratio: 0.04404768557648558
Market cap (USD): 817635.1635135135
Debt to equity: 1.9024793388429753
Current ratio: 0.6952453694863472
Quick ratio: 0.3859079625739928
Effective tax rate (%): 30.021834061135372
Interest coverage ratio: 1.8372739916550762
COGS to revenue (%): 82.58671872910594
SG&A to revenue (%): 4.455617662004226
Free cash flow (dilution-adjusted): -7005681.818181818
Buyback yield (%): 0
Retained earnings: -20421590.90909091
Inventory turnover: 9.530864197530866
Receivables turnover: 25.14525891055817
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.412465716851533
FCF margin (%): -16.48792490171432
Rule of 40 score: -16.48792490171432
Financial ratios for DKL.L — annual report dated 2022-12-31
Total revenue: 33196808.5106383
Gross profit: 5340425.531914894
Operating income: 1250000
Net income: -886170.2127659575
Capital expenditures: 2510638.297872341
Operating cash flow: 602127.6595744682
Depreciation & amortization: 1653191.4893617022
Net tangible assets: 16304255.319148937
Owner earnings: -1743617.021276596
Return on net tangible assets (%): -10.694245073730915
Capex to operating income (%): 200.85106382978725
Buffett classification: The Gruesome
Stock price: 0.00036144578313253013
Shares outstanding: 1210100042
Book value: 16304255.319148943
P/B ratio: 0.026826466390997884
Market cap (USD): 437385.5573493976
Debt to equity: 2.1969202662142755
Current ratio: 0.7654969718560741
Quick ratio: 0.48423583897399364
Interest coverage ratio: 0.7014925373134328
COGS to revenue (%): 83.91283448165359
SG&A to revenue (%): 5.467072584521711
Free cash flow (dilution-adjusted): -2127659.574468085
Buyback yield (%): 0
Retained earnings: -20004255.31914894
Inventory turnover: 8.291640278657379
Receivables turnover: 19.901147959183675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7041332965110927
FCF margin (%): -6.409229290177855
Revenue growth (%): -21.871061246391633
Rule of 40 score: -28.28029053656949
Financial ratios for DKL.L — annual report dated 2023-12-31
Total revenue: 42554444.44444444
Gross profit: 2288888.888888889
Operating income: -1668888.8888888888
Net income: -4953333.333333333
Capital expenditures: 2168888.888888889
Operating cash flow: 2174444.4444444445
Depreciation & amortization: 4558888.888888889
Net tangible assets: 12166666.666666666
Owner earnings: -2563333.333333333
Return on net tangible assets (%): -21.06849315068493
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 1210100042
Book value: 12166666.666666664
P/B ratio: 0.02517981706953356
Market cap (USD): 306354.44101265824
Debt to equity: 2.9999086757990874
Current ratio: 0.4276700624383832
Quick ratio: 0.22806441012159054
Interest coverage ratio: -0.673542600896861
COGS to revenue (%): 94.62126948484295
SG&A to revenue (%): 3.1384631452518343
Free cash flow (dilution-adjusted): -55555.555555555555
Buyback yield (%): 0
Retained earnings: -25846666.666666664
Inventory turnover: 11.932499176819228
Receivables turnover: 24.37873965626989
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.242817999491539
FCF margin (%): -0.1305517115329382
Revenue growth (%): 28.18836012747243
Rule of 40 score: 28.05780841593949
Financial ratios for DKL.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 7782291.666666667
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 1210100042
Book value: 7782291.666666664
P/B ratio: 0.019436756129032267
Market cap (USD): 151262.50525000002
Debt to equity: 4.449471288984073
Current ratio: 0.3648561890087314
Quick ratio: 0.1752054442732409
Buyback yield (%): 0
Retained earnings: -27882291.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DKL.L — annual report dated 2024-12-31
Total revenue: 31209375
Gross profit: 2883333.3333333335
Operating income: -1057291.6666666667
Net income: -3651041.666666667
Capital expenditures: 393750
Operating cash flow: 1205208.3333333335
Depreciation & amortization: 3715625
Net tangible assets: 7782291.666666667
Owner earnings: -329166.666666667
Return on net tangible assets (%): -4.229688127426051
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 1210100042
Book value: 7782291.666666664
P/B ratio: 0.019436756129032267
Market cap (USD): 151262.50525000002
Debt to equity: 4.449471288984073
Current ratio: 0.3648561890087314
Quick ratio: 0.1752054442732409
Interest coverage ratio: -0.5100502512562815
COGS to revenue (%): 90.76132305330263
SG&A to revenue (%): 4.375688394913388
Free cash flow (dilution-adjusted): 784375
Buyback yield (%): 0
Retained earnings: -27882291.666666668
Inventory turnover: 9.205484089370346
Receivables turnover: 58.40350877192982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.269236963313686
FCF margin (%): 2.513267247421648
Revenue growth (%): -26.66012820178072
Rule of 40 score: -24.14686095435907
Financial ratios for DPABHUSHAN.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.909930106817882
Shares outstanding: 22827920
Market cap (USD): 112083491.68403006
Buyback yield (%): 0
Retained earnings: 13863721.482262958
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPABHUSHAN.NS — annual report dated 2023-03-31
Total revenue: 240574933.0085262
Gross profit: 14633227.771010963
Operating income: 8966382.46041413
Net income: 5519719.853836785
Capital expenditures: 133714.98172959805
Operating cash flow: 7426504.263093788
Depreciation & amortization: 598209.5006090135
Net tangible assets: 22054689.40316687
Owner earnings: 5984214.372716201
Return on net tangible assets (%): 27.13352368434133
Capex to operating income (%): 1.4912924172032491
Buffett classification: The Great
Stock price: 3.766869671132765
P/E ratio: 15.578652862839249
Shares outstanding: 22827920
Book value: 22055298.416565165
P/B ratio: 3.8988272966853335
Market cap (USD): 85989799.50304507
Debt to equity: 0.6984238488131924
Current ratio: 1.8139659144460467
Quick ratio: 0.06718470761682659
Effective tax rate (%): 25.278740531396025
Interest coverage ratio: 6.700649001920609
COGS to revenue (%): 93.91739297689325
SG&A to revenue (%): 0.9384897182460085
Free cash flow (dilution-adjusted): 7291498.1729598055
Buyback yield (%): 0
Retained earnings: 18044031.668696713
Inventory turnover: 5.358058832364733
Receivables turnover: 3011.3130050312548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.88153904473086
FCF margin (%): 3.030863640602734
Rule of 40 score: 3.030863640602734
Financial ratios for DPABHUSHAN.NS — annual report dated 2024-03-31
Total revenue: 280598536.9948435
Gross profit: 18042595.035375945
Operating income: 11655666.147020027
Net income: 7418407.48291162
Capital expenditures: 393884.15877203504
Operating cash flow: -33721.069672622616
Depreciation & amortization: 670020.3861374266
Net tangible assets: 28588751.64887876
Owner earnings: 7694543.710277012
Return on net tangible assets (%): 26.914584465876068
Capex to operating income (%): 3.379336314233214
Buffett classification: The Great
Stock price: 10.032389635316699
P/E ratio: 30.871664643845126
Shares outstanding: 22827920
Book value: 28630603.18983092
P/B ratio: 7.999083584979519
Market cap (USD): 229018588.00383878
Debt to equity: 0.7237745161687551
Current ratio: 1.7209732138693856
Quick ratio: 0.11528336891723673
Effective tax rate (%): 25.813434196135614
Interest coverage ratio: 8.393198853234777
COGS to revenue (%): 93.56996111647314
SG&A to revenue (%): 0.8275356774222885
Free cash flow (dilution-adjusted): -473869.768557381
Buyback yield (%): 0
Retained earnings: 24681388.655714113
Inventory turnover: 4.816754871195575
Receivables turnover: 4065.8752389226756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.224165832613984
FCF margin (%): -0.16887820358311034
Revenue growth (%): 16.636647669729914
Rule of 40 score: 16.467769466146805
Financial ratios for DPABHUSHAN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 40243991.87768753
Buffett classification: The Gruesome
Stock price: 19.619565217391305
Shares outstanding: 22827920
Book value: 40293227.42474917
P/B ratio: 11.115363395841934
Market cap (USD): 447873865.2173913
Debt to equity: 0.5873697029272689
Current ratio: 1.7982491487900834
Quick ratio: 0.15362779754925313
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPABHUSHAN.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.465322298636202
Shares outstanding: 22827920
Market cap (USD): 398696980.20748335
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPABHUSHAN.NS — annual report dated 2025-03-31
Total revenue: 387045838.2043488
Gross profit: 31079822.30535422
Operating income: 19155997.194295064
Net income: 13174596.679915829
Capital expenditures: 2944411.9710077154
Operating cash flow: -2212426.9347673603
Depreciation & amortization: 1065209.25882628
Net tangible assets: 47210112.22819733
Owner earnings: 11295393.967734393
Return on net tangible assets (%): 23.925793510374156
Capex to operating income (%): 15.3707057959092
Buffett classification: The Great
Stock price: 15.872330493639865
P/E ratio: 27.502344058451
Shares outstanding: 22827920
Book value: 47245148.46855272
P/B ratio: 7.6691957262775174
Market cap (USD): 362332290.72237134
Debt to equity: 0.45508010936939386
Current ratio: 1.8396653368702893
Quick ratio: 0.08728751388423431
Effective tax rate (%): 25.355601699602254
Interest coverage ratio: 11.34830184497756
COGS to revenue (%): 91.96998927839009
SG&A to revenue (%): 0.9452124433983297
Free cash flow (dilution-adjusted): -5168950.198737432
Buyback yield (%): 0
Retained earnings: 37209422.49240121
Inventory turnover: 4.2167809400096115
Receivables turnover: 1518.7807238864168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.53438019790151
FCF margin (%): -1.3354878643620445
Revenue growth (%): 37.935800503286835
Rule of 40 score: 36.60031263892479
Financial ratios for DPABHUSHAN.NS — quarterly report dated 2025-03-31
Total revenue: 83848094.45873275
Gross profit: 7816635.492167407
Operating income: 4466834.229600186
Net income: 2940483.9841010054
Capital expenditures: 0
Depreciation & amortization: 441150.3390226794
Net tangible assets: 47210112.22819733
Owner earnings: 3381634.3231236846
Return on net tangible assets (%): 7.162944893623713
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.872330493639865
P/E ratio: 30.805497724309767
Shares outstanding: 22827920
Book value: 47245148.46855272
P/B ratio: 7.6691957262775174
Market cap (USD): 362332290.72237134
Debt to equity: 0.45508010936939386
Current ratio: 1.8396653368702893
Quick ratio: 0.08728751388423431
Effective tax rate (%): 27.2665496511221
Interest coverage ratio: 9.47745312034924
COGS to revenue (%): 90.6776229768531
Buyback yield (%): 0
Retained earnings: 37209422.49240121
Inventory turnover: 0.9006702682042214
Receivables turnover: 329.02270746364513
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.985524832697092
Rule of 40 score: 0
Financial ratios for DPABHUSHAN.NS — quarterly report dated 2025-06-30
Total revenue: 63230891.64521414
Gross profit: 9191036.742335597
Operating income: 6046302.3636789145
Net income: 4262064.123566581
Capital expenditures: 0
Depreciation & amortization: 307371.86988064594
Owner earnings: 4569435.9934472265
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.718932834074423
P/E ratio: 52.98936647369612
Shares outstanding: 22827920
Market cap (USD): 381658461.2216242
Effective tax rate (%): 25.04367904085148
Interest coverage ratio: 12.83258828788556
COGS to revenue (%): 85.46432526381865
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -24.588755351698204
Rule of 40 score: -24.588755351698204
Financial ratios for DPABHUSHAN.NS — quarterly report dated 2025-09-30
Total revenue: 109092886.1330327
Gross profit: 11720281.848928973
Operating income: 8229549.041713641
Net income: 5801634.723788049
Capital expenditures: 0
Depreciation & amortization: 306426.15558060876
Net tangible assets: 57114284.103720404
Owner earnings: 6108060.879368658
Return on net tangible assets (%): 10.69445406735087
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.10822998872604
P/E ratio: 28.276854477527998
Shares outstanding: 22827920
Book value: 57138974.06989854
P/B ratio: 6.43549156263127
Market cap (USD): 367717385.52423894
Debt to equity: 0.4455104319518442
Current ratio: 1.9976053254583421
Quick ratio: 0.10173488696874668
Effective tax rate (%): 25.752211112553923
Interest coverage ratio: 19.325452716297786
COGS to revenue (%): 89.25660300650884
Buyback yield (%): 0
Inventory turnover: 1.0095626722648607
Receivables turnover: 262.30791542423424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.87095070114751
Revenue growth (%): 72.53099441511638
Rule of 40 score: 72.53099441511638
Financial ratios for DPABHUSHAN.NS — quarterly report dated 2025-12-31
Total revenue: 136167639.52322602
Gross profit: 15260888.938398128
Operating income: 11466079.982176675
Net income: 8171426.980060154
Capital expenditures: 0
Depreciation & amortization: 301069.399576696
Owner earnings: 8472496.37963685
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.900634955998665
P/E ratio: 17.141344497542875
Shares outstanding: 22827920
Market cap (USD): 362978422.72474104
Effective tax rate (%): 25.36047920764274
Interest coverage ratio: 22.13712712648128
COGS to revenue (%): 88.79257289629737
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 24.8180741658784
Rule of 40 score: 24.8180741658784
Financial ratios for DPM.AX — quarterly report dated 2025-09-30
Total revenue: 192383453.2374101
Gross profit: 110479136.69064748
Operating income: 82648920.86330935
Net income: 69053956.83453238
Capital expenditures: 0
Operating cash flow: 132788489.20863311
Depreciation & amortization: 20274100.71942446
Net tangible assets: 1733663309.352518
Owner earnings: 89328057.55395684
Return on net tangible assets (%): 5.152560884922848
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.184210526315788
P/E ratio: 32.12793228117893
Shares outstanding: 221041933
Book value: 1743439568.3453238
P/B ratio: 2.8126244613512883
Market cap (USD): 4903640776.815789
Debt to equity: 0
Current ratio: 2.7736476771678698
Quick ratio: 2.494859895200971
Effective tax rate (%): 11.445599726914597
Interest coverage ratio: 63.64653739612188
COGS to revenue (%): 42.573472493857814
SG&A to revenue (%): 8.106187806875505
Free cash flow (dilution-adjusted): 127173381.29496405
Buyback yield (%): 0
Retained earnings: 602340287.7697842
Inventory turnover: 1.6309523809523812
Receivables turnover: 1.2778494561997056
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.276534489009929
FCF margin (%): 66.10411610505099
Revenue growth (%): 41.331744805402984
Rule of 40 score: 107.43586091045398
Financial ratios for DPM.AX — quarterly report dated 2025-12-31
Total revenue: 257251094.89051092
Gross profit: 183527007.29927006
Operating income: 140419708.02919707
Net income: 114845255.47445254
Capital expenditures: 0
Operating cash flow: 105946715.32846715
Depreciation & amortization: 25810218.97810219
Net tangible assets: 1868246715.328467
Owner earnings: 140655474.45255473
Return on net tangible assets (%): 7.528741964244552
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.06711409395973
P/E ratio: 25.67404346088588
Shares outstanding: 221041933
Book value: 1877455474.4525547
P/B ratio: 3.657681924021545
Market cap (USD): 6867134952.060403
Debt to equity: 0.004829490450267756
Current ratio: 3.5835332867021417
Quick ratio: 3.339100254110481
Effective tax rate (%): 14.037982429301982
COGS to revenue (%): 28.658415476372884
SG&A to revenue (%): 10.489623589097533
Free cash flow (dilution-adjusted): 101453284.67153284
Buyback yield (%): 0
Retained earnings: 719497810.218978
Inventory turnover: 1.8292824283696165
Receivables turnover: 1.4501248781049798
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.737012930161995
FCF margin (%): 39.43745495610526
Revenue growth (%): 33.717890266296
Rule of 40 score: 73.15534522240127
Financial ratios for DPM.AX — annual report dated 2025-12-31
Total revenue: 693781751.8248174
Gross profit: 442278832.11678827
Operating income: 314107299.270073
Net income: 269508029.19708025
Capital expenditures: 0
Operating cash flow: 475983211.67883205
Depreciation & amortization: 78397080.29197079
Net tangible assets: 1868246715.328467
Owner earnings: 347905109.48905104
Return on net tangible assets (%): 18.622011034976392
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.06711409395973
P/E ratio: 25.480261098413308
Shares outstanding: 221041933
Book value: 1877455474.4525547
P/B ratio: 3.657681924021545
Market cap (USD): 6867134952.060403
Debt to equity: 0.004829490450267756
Current ratio: 3.5835332867021417
Quick ratio: 3.339100254110481
Effective tax rate (%): 12.501333004722984
Interest coverage ratio: 146.6690524880709
COGS to revenue (%): 36.25101396030011
SG&A to revenue (%): 9.075299769274716
Free cash flow (dilution-adjusted): 460663503.649635
Buyback yield (%): 1.2344314417072357
Retained earnings: 719497810.218978
Inventory turnover: 6.240428152280219
Receivables turnover: 3.9108489653838716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.070141978936045
FCF margin (%): 66.39890750051816
Revenue growth (%): 63.44661957809805
Rule of 40 score: 129.84552707861621
Financial ratios for EQS.PA — annual report dated 2021-12-31
Total revenue: 219396590.9090909
Gross profit: 152063636.36363637
Operating income: 57120454.54545455
Net income: 46761363.63636363
Capital expenditures: 11843181.818181818
Depreciation & amortization: 12872727.272727273
Net tangible assets: 40722727.27272727
Owner earnings: 47790909.090909086
Return on net tangible assets (%): 117.35684786248464
Capex to operating income (%): 20.733696733378427
Buffett classification: The Great
Stock price: 95
P/E ratio: 30.53929738031592
Shares outstanding: 15032202
Book value: 187767045.45454544
P/B ratio: 7.605483627560748
Market cap (USD): 1428059190
Debt to equity: 0
Current ratio: 1.2997033902809818
Quick ratio: 1.20536236352232
Effective tax rate (%): 20.483693660681567
Interest coverage ratio: 85.34125636672327
COGS to revenue (%): 30.690064173948173
Buyback yield (%): 0.4102834777521308
Retained earnings: 44453409.09090909
Inventory turnover: 6.6771467207572694
Receivables turnover: 5.168768238160255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.309355750846805
Rule of 40 score: 0